To study the effect of musta amalaki takradhara in the management of Hypertension

An open randomized control clinical trial of musta amalaki takradhara in uccha rakta chapa with special reference to essential hypertension - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090559

Enrollment

Registered

2025-07-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Essential Hypertension Systolic blood pressure is 140 to 159 mm of Hg and diastolic blood pressure is 90 to 99 mm of Hg with or without allopathic medicine Chronicity less than 2 years

Exclusion criteria

Exclusion criteria: Secondary Hypertension Pregnancy induced hypertension Gestational hypertension Patients having history of acute coronary syndrome cardiomyopathies MI Stroke Pregnant and lactating womens Alcohol and drug abusers

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of musta amalaki takradhara in Uccha Rakta ChapaTimepoint: 4 weeks	—

Secondary

Measure	Time frame
1 To review Uccha Rakta Chapa in detail 2 To review Essential Hypertension in detail 3 To review Takradhara procedure for Hypertension 4 To review Manasyadi Kwath Shirodhara procedure for Hypertension 5 To find out adverse drug reaction of either drug or procedureTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Alaknanda Kulkarni

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta

Vdalaknandakulkarni@gmail.com9860359489

Outcome results